Skip to main content

Table 1 Bladder cancer patients

From: Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction

  Patient number N (%)
  Total qPCR analysis ELISA analysis Chemotaxis
Patients 23(100) 20(100) 11(100) 3(100)
Male 15(65) 14(70) 6(55) 1(33)
Female 8(35) 6(30) 5(45) 2(67)
Tumor stage:     
Stage 0 4(17) 4(20) 2(18)  
Stage 0is 1(4) 1(5)   
Stage 1 6(26) 5(25) 3(27) 1(33)
Stage 2 2(9) 2(10) 1(9)  
Stage 3 8(35) 6(30) 4(36) 2(67)
Stage 4 2(9) 2(10) 1(9)  
Prior treatment:     
None 15(65) 13(65) 7(64) 2(67)
BCG 5(22) 5(25) 2(18)  
Other treatment 3(13) 2(10) 2(18) 1(33)